Active substance
Ambroxol
- SFDA 15
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AMBOLAR | 3 mg/ml | Syrup · Oral use | 1 Bottle | SAR 7.15 | Generic · OTC | DAR ALDAWA | Valid |
| MUCOSOLVAN 30MG-5ML ORAL LIQUID | 6 mg/ml | Oral liquid · Oral use | 1 Bottle | SAR 17.40 | Generic · OTC | Sanofi-Aventis Deutschland GmbH | Valid |
| MUCOSOLVAN 30MG-5ML ORAL LIQUID | 6 mg/ml | Oral liquid · Oral use | 1 Bottle | SAR 34.90 | Generic · OTC | A. Nattermann and Cie Gmbh | Valid |
| MUCOSOLVAN LA 75MG CAPS | 75 mg | Capsule · Oral use | 10 Blister | SAR 17.85 | Generic · OTC | A. Nattermann and Cie Gmbh | Valid |
| MUCOSOLVAN TAB 30MG | 30 mg | Tablet · Oral use | 20 Blister | SAR 14.70 | NCE · OTC | A. Nattermann and Cie Gmbh | Valid |
| MUCUM 15MG-5ML SYRUP | 3 ml | Syrup · Oral use | 1 Bottle | SAR 7.15 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| MUCUM 30MG TABLETS | 30 mg | Tablet · Oral use | 20 Blister | SAR 8.45 | Generic · OTC | Gulf Pharmaceutical Industries (Julphar) | Valid |
| AMBROSIA | 3 mg/ml | Syrup · Oral use | 1 Bottle | SAR 5.20 | Generic · OTC | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
| Ambrolyt | 6 mg/ml | Oral solution · Oral use | 1 Bottle | SAR 13.25 | Generic · Prescription | JERASH PHARMACEUTICALS LIMITED COMPANY | Suspended · Not Marketed |
| MEDROXOL 15MG\5ML SYRUP | 3 mg/ml | Syrup · Oral use | 1 Bottle | SAR 4.25 | Generic · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| MUCOSOLVAN 15MG-5ML ORAL LIQUID | 3 mg/ml | Oral liquid · Oral use | 1 Bottle | SAR 9.85 | Generic · OTC | SANOFI AVENTIS DEUTSCHLAND GMBH | Withdrawn by MAH · Not Marketed |
| MUCOSOLVAN LIQUID 15MG-5ML | 3 mg/ml | Oral liquid · Oral use | 1 Bottle | SAR 9.85 | NCE · OTC | BOEHRINGER INGELHEIM | Withdrawn by MAH · Not Marketed |
| MUCOSOLVAN TAB 30MG | 30 mg | Tablet · Oral use | 20 Blister | SAR 12.30 | NCE · OTC | BOEHRINGER INGELHEIM | Withdrawn by MAH · Not Marketed |
| RIABROXOL | 3 mg/ml | Syrup · Oral use | 1 Bottle | SAR 4.70 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| RIABROXOL | 30 mg | Tablet · Oral use | 20 Blister | SAR 7.10 | Generic · OTC | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.